ArticlePharmacology research & perspectives2019

Inhibiting the immunoproteasome's β5i catalytic activity affects human peripheral blood-derived immune cell viability.

Katrien Pletinckx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.